COMPASS Pathways plc (CMPS)
NASDAQ: CMPS · Real-Time Price · USD
5.82
+0.14 (2.46%)
At close: Dec 5, 2025, 4:00 PM EST
5.88
+0.06 (1.02%)
After-hours: Dec 5, 2025, 7:58 PM EST
COMPASS Pathways Employees
COMPASS Pathways had 166 employees as of December 31, 2024. The number of employees decreased by 20 or -10.75% compared to the previous year.
Employees
166
Change (1Y)
-20
Growth (1Y)
-10.75%
Revenue / Employee
n/a
Profits / Employee
-$1,429,614
Market Cap
558.82M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 166 | -20 | -10.75% |
| Dec 31, 2023 | 186 | 5 | 2.76% |
| Dec 31, 2022 | 181 | 65 | 56.03% |
| Dec 31, 2021 | 116 | 54 | 87.10% |
| Dec 31, 2020 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CMPS News
- 16 days ago - Compass Pathways to Participate in Two Investor Conferences in December - Business Wire
- 4 weeks ago - Compass Pathways to Participate in Stifel 2025 Healthcare Conference - Business Wire
- 4 weeks ago - COMPASS Pathways plc (CMPS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Compass Pathways to expedite launch timing of its experimental depression therapy - Reuters
- 4 weeks ago - Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months - Business Wire
- 5 weeks ago - NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression - PRNewsWire
- 5 weeks ago - Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors - Business Wire
- 5 weeks ago - Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025 - Business Wire